Sedative/Tranquilizers Flashcards
1
Q
Acepromazine
A
- Most commonly used phenothiazine
- Has antiemetic, antihistamine and antiarrhythmic properties
- Slight decrease in gastrointestinal motility
- IV, IM or SQ
- duration:6-8 hrs
- 0.01-0.05mg/kg
- No analgesia
- No reversal agent
- blockade of alpha-1 adrenergic receptors = peripheral vasodilation = hypotension
- inhibiti platelet aggregation (do no use in patients with low platelet counts or bleeding disorder)
- possibly decrease seizure threshold (controversial)
- Boxers of European bloodlines could be more sensitive to effects - fainting and sudden collapse -use low end of dose
2
Q
Benzodiazepines
A
- Diazepam and Midazolam
- axiolytic properties and mild sedation
- skeletal muscle relaxation
- first line anticonvulsant
- minimal effect on cardiovascular and respiratory system
- no analgesia
- not a reliable source of sedation in healthy animals - can cause excitement, more difficult to handle, aggression when administered alone
- highly protein bound - care when use in patients with hypoalbuminemia
- may worsen the signs of hepatic encephalopathy - do not use
- Diazepam
- insoluble in water and prepared in propylene glycol
- hence not recommended in IM and SQ injection due to unreliable absorption and pain on injection
- SLOW IV
- fast IV: dysrhythmias, thrombophelbitis due to propylene glycol carrier
- incompatible with most drugs and solutions
- do not mix with atropine, acepromazine, barbiturates or opioids as precipitate will form
- been mixed with ketamine but cant be explain why it works
- absorbs into plastic which can decrease the active drug concentration in solution
- do not store in plastic syringes, fluid administration sets or fluid bags for more than 2 hours
- Midazolam
- water soluble
- can be mixed with other drugs and administered IV, IM, SQ
- Flumazenil
- reversal agent for benzodiazepines
- expensive
- competitive blocker of benzos at the GABA receptors in the CNS
- IV and to effect (usually 2 mins post injection)
3
Q
Alpha-2 Agonists (Xylazine, Medetomidine, Dexmedetomidine)
A
- Dexmedetomidine
- commonly used
- profound sedation and muscle relaxation
- analgesic effects shorter than sedative effects
- minimal respiratory effect
- cause up to 80% reduction in induction agents
- 50% reduction in inhalant concentration
- more predictable sedation compared to phenothiazine and benzodiazepines
- sedation won’t occur in frightened, stressed or excited prior to administration or when placed in a noisy environment after administration
- place patients in a quiet environment for 20 mins prior to administration and at least 20 mins post injection to allow maximum effect
*can be used post operatively as CRI to enhance analgesia and sedation while keeping dose of opioids at a minimum
- biphasic effect on blood pressure
- Initial hypertension due to vasoconstriction
- once central and peripheral pre-synaptic alpha-2 receptors activated= sustained decrease in blood pressure due to vasodilation (blocking norepinephrine)
- significant bradycardia:
1) a decrease in sympathetic drive allows vagal tone to predominate
2) baroreceptor reflex responds to initial hypertension with a reflex bradycardia - decrease cardiac output
- bradyarrhythmias : sinoatrial block, sinus arrhythmia, and atrioventricular block (1st, 2nd and 3rd degrees) are common
- despite above, perfusion to vital organs are still maintained within acceptable range
- inhibits antidiuretic hormone (ADH) and insulin release
- causes diuresis and hyperglycemia
- can cause aggression in heavily sedated dogs
- plateau can be reached where increases in dose will prolong duration of action and enhance adverse effects but not no further sedation is achieved
- use of anticholinergic to counteract the bradycardia is controversial
- can lease to increase in myocardial workload and myocardial oxygen demand
- may precipitate arrhythmias without showing improvement in cardiac output
- bradycardia is a normal physiological response
- no need to treat if there is normal BP
- but if not, used alpha-2 antagonist for reversal
- ensure adequate analgesia on board before reversal if on analgesia
- Atipamezole
- reversal agent for medetomidine and dexmedetomidine
- binds to and inhibits alpha-2 receptors
- reversal occurs very quickly and can be aggressive and apprehensive
- IM recommended but in ECC can be used IV when diluted in saline and titrated to effect
- Yohimbine and Tolazoline
- reversal agent for xylazine
- binds to alpha-2 receptors
- Tolazoline also binds to alpha-1 receptors
- onset of action 1-3 mins for Yohimbine and 5 mins for Tolazoline
- short duration of action
- IV administration
- dilute total dose in 5mL of saline and titrate slowly to effect
- side effects: rapid arousal, excitement, rage and/or tremors
- can cause vasodilation and hypotension if administered too quickly